Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis.

aortic valve and root cardiology/cardiologist heart valve percutaneous reoperation transapical

Journal

The Thoracic and cardiovascular surgeon reports
ISSN: 2194-7635
Titre abrégé: Thorac Cardiovasc Surg Rep
Pays: United States
ID NLM: 101629509

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 10 09 2020
accepted: 15 10 2020
entrez: 25 1 2021
pubmed: 26 1 2021
medline: 26 1 2021
Statut: ppublish

Résumé

Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs). The new self-expanding transcatheter heart valve Allegra, from New Valve Technology with its special implantation mechanism, has proven its safety and feasibility for patients with degenerated SAVs, but it has never been used in the latest-generation sutureless SAV. To the best of our knowledge, this is the first description of the successful VIV of the Allegra prosthesis into a degenerated sutureless SAV, and the procedure yielded an excellent postinterventional hemodynamic results.

Identifiants

pubmed: 33489712
doi: 10.1055/s-0040-1721483
pii: 200378crc
pmc: PMC7815337
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e1-e5

Informations de copyright

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).

Déclaration de conflit d'intérêts

Conflict of Interest None declared.

Références

Innovations (Phila). 2017 May/Jun;12(3):155-173
pubmed: 28570342
J Am Coll Cardiol. 2017 May 9;69(18):2253-2262
pubmed: 28473128
Circ Cardiovasc Interv. 2017 Apr;10(4):
pubmed: 28400461
EuroIntervention. 2019 May 20;15(1):37-43
pubmed: 30777843
JACC Cardiovasc Interv. 2020 May 11;13(9):1071-1082
pubmed: 32305398
JACC Cardiovasc Interv. 2017 May 22;10(10):1034-1044
pubmed: 28521921
EuroIntervention. 2019 Oct 04;15(9):e757-e763
pubmed: 31355750
Circ J. 2018 Sep 25;82(10):2655-2662
pubmed: 30068793

Auteurs

Maximilian Vondran (M)

Department of Cardiac and Thoracic Vascular Surgery, University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany.
Department of Cardiac and Vascular Surgery, Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany.

Bernd Abt (B)

Department of Cardiology, Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany.

Holger Nef (H)

Department of Cardiology, Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany.
Department of Cardiology, University Hospital Giessen and Marburg, Campus Giessen, Giessen, Germany.

Ardawan J Rastan (AJ)

Department of Cardiac and Thoracic Vascular Surgery, University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany.
Department of Cardiac and Vascular Surgery, Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany.

Classifications MeSH